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The GTPase Rap1 controls functional activation of macrophage
integrin αMβ2 by LPS and other inflammatory mediators
Emmanuelle Caron, Annette J. Self and Alan Hall*
Background: β2 integrins mediate many aspects of the inflammatory and
immune responses, including adhesion of leukocytes to the endothelium,
complement-mediated phagocytosis in macrophages and neutrophils, and
antigen-specific conjugate formation between cytotoxic T cells and their
targets. A variety of inflammatory mediators, such as tumor necrosis factor-α
(TNF-α), platelet-activating factor (PAF), and lipopolysaccharide (LPS) and
other bacterial products induce the functional activation of β2 integrins, but
the signaling events that link membrane receptors to integrin activation are
poorly understood. 
Results: We report here that expression of the constitutively active small
GTPases Rap1 or R-ras, but not Ras or RalA, is sufficient for functional
activation of αMβ2, the complement receptor 3 (CR3), in macrophages,
allowing phagocytosis of C3bi-opsonized targets. Inhibition of Rap1, but not
other Ras-like or Rho-like small GTPases, abolishes activation of αMβ2 induced
by phorbol esters, LPS, TNF-α or PAF. Finally, Rap1 activation specifically
controls the binding properties of αMβ2 towards its physiological ligand,
namely the complement-opsonized phagocytic targets.
Conclusions: In macrophages, the Rap1 GTPase regulates activation of the
αMβ2 integrin in response to a wide variety of inflammatory mediators.
Background
Leukocytes, which are responsible for mediating inflam-
mation and immunity, remain inactive and non-adherent
while circulating in the blood, but can be rapidly activated
and recruited to tissues in response to inflammatory medi-
ators or infection. Integrins of the β2 subfamily are
required for leukocyte adhesion to endothelial cells and
migration into tissues; they also mediate effector func-
tions, such as the interaction of natural killer (NK) and
cytotoxic T cells with their targets, the binding of T cells
to antigen-presenting cells and the phagocytosis of com-
plement-opsonized particles [1,2]. This crucial role of β2
integrins is most clearly demonstrated in patients with
leukocyte adhesion deficiency (LAD) syndrome, where
mutations in this integrin chain (CD18) dramatically
increase susceptibility to bacterial infections [3]. Func-
tional activation of the three major β2-containing inte-
grins, αLβ2 (CD11a/CD18, LFA-1), αMβ2 (CD11b/CD18,
CR3), and αXβ2 (CD11c/CD18, p150,95), is induced in
several pro-inflammatory conditions, for example after
T-cell receptor crosslinking and in response to a variety of
inflammatory mediators such as lipopolysaccharide (LPS)
and other bacterial products, tumor necrosis factor-α
(TNF-α) and platelet-activating factor (PAF) [1,4–9]. The
signal transduction pathway linking the membrane recep-
tors for these diverse agonists to β2 integrin activation is
not clear. As there have been several reports that small
GTPases of the Ras family can regulate integrin function
in a variety of cell types [10–14] we have examined their
role in the activation of the αMβ2 complement receptor in
the macrophage. We show that the Rap1 GTPase specifi-
cally regulates functional activation of the αMβ2 integrin
in response to a wide variety of inflammatory mediators.
Results and discussion
To determine whether Ras-like small GTPases are
involved in activation of the αMβ2 CR3 receptor, we first
made use of TcdB-1470, a Clostridium difficile toxin that
has been reported to glucosylate and inactivate Rac and
also three members of the Ras family — R-ras, RalA and
Rap1 [15]. As shown in Figure 1a, TcdB-1470 completely
abolished (at least 95% inhibition) the phagocytosis of
C3bi-opsonized sheep red blood cells in J774.A1 murine
macrophage cells stimulated with the phorbol ester PMA.
Inhibition of phagocytosis by TcdB-1470 was concentra-
tion-dependent and did not affect cell viability (data not
shown). Using flow cytometry, we confirmed that PMA
(and TcdB-1470) does not affect the surface expression of
αMβ2 (Figure 1b).
As we have previously shown that Rac is not involved in
CR3-mediated phagocytosis [16], the toxin result suggests
that the three Ras-like GTPases, R-ras, RalA or Rap1
might be involved in PMA-induced αMβ2 activation. To
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determine whether Ras-like small GTPases can activate
αMβ2, expression constructs encoding constitutively acti-
vated versions of R-ras (V38), RalA (L72), Rap1 (V12) and
Ras (V12) were microinjected into macrophage cells and
phagocytosis of C3bi-opsonized particles determined.
Figure 2a shows that expression of either R-Ras (V38) or
Rap1 (V12) was sufficient to trigger efficient CR3-medi-
ated phagocytosis. Both the phagocytic index and the per-
centage of cells able to phagocytose C3bi-opsonized RBC
increased dramatically upon macrophage activation or
expression of active R-Ras or Rap1 (control, 9 ± 4%; PMA-
activated cells, 69 ± 10%; R-Ras(V38)-expressing cells,
67 ± 4%; Rap1(V12)-expressing cells, 68 ± 11%; n = 3).
Control cells never show more than one internalized parti-
cle per cell, whereas >50% of R-ras, Rap1-expressing and
PMA-activated cells show between two and seven phago-
cytosed particles per cell. By contrast, RalA (L72) or Ras
(V12) did not induce β2-dependent phagocytosis
(Figure 2b). We conclude that when overexpressed, two
members of the Ras family, R-Ras and Rap1, can induce
functional activation of the αMβ2 integrin in macrophages. 
To identify which of these GTPases actually mediates
integrin activation in macrophages, we first microinjected
J774.A1 cells with expression constructs encoding domi-
nant-negative versions of R-ras and Rap1 and then acti-
vated the cells with PMA. As shown in Figure 2c,
dominant-negative Rap1 (N17) completely inhibited
phagocytosis to below control levels, whereas dominant
negative R-Ras (N43), Rac (N17) and RalA (N28) had no
effect on CR3-mediated phagocytosis of C3bi-opsonized
targets. To confirm the specificity of the dominant-nega-
tive Rap1, a construct encoding a Rap-specific GTPase-
activating protein, Rap1GAP [17], was microinjected into
macrophages and this also completely inhibited PMA-
induced activation of αMβ2 and phagocytosis (Figure 2c).
In a further control, we have shown that expression of
Rap1 (N17) does not affect the ability of J774 cells to
phagocytose IgG-opsonized targets (data not shown), a
process known to be independent of macrophage activa-
tion [18]. Ras has been reported to downregulate integrin
function in some cell types [13,19]. To determine
whether Ras exerts a tonic inhibitory effect on αMβ2 in
macrophages, we injected a dominant-negative Ras (N17)
construct. This did not lead to activation of CR3 function
nor did it inhibit PMA-induced activation (Figure 2c). 
To determine whether Rap1 regulates the ability of
αMβ2 to interact with complement-opsonized targets, or
the ability of αMβ2 integrin to internalize bound parti-
cles, we measured the effect of modifying Rap1 on parti-
cle binding. Figure 2d shows that expression of active
Rap1 or R-Ras induces a two- to threefold increase in the
number of C3bi-opsonized RBC bound by macrophages.
In non-activated J774 cells, inhibition of Rap1, either
through expression of the dominant-negative Rap1 or
after treatment with TcdB-1470, reduced binding to
around one particle per cell. An anti-CR3 antibody
(M1/70), that is known to block C3bi binding [2] and that
inhibits by ≥95% the number of C3bi-opsonized particles
that bind to CR3-transfected COS cells [16], also reduces
the number of bound particles to one per cell. We con-
clude therefore that inhibition of Rap1 in J774
macrophage cells essentially eliminates binding of C3bi-
opsonized red blood cells to the αMβ2 complement
receptor. TcdB-10463, another C. difficile toxin that inhibits
Rho, Rac and Cdc42 [20] and has previously been shown
to inhibit CR3-mediated phagocytosis [16], did not affect
binding of C3bi-opsonized RBC to macrophages (data not
shown). Neither Rap1 (N17) nor TcdB-1470 affected the
ability of J774 cells to bind IgG-opsonized targets (data
not shown).
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Figure 1
A Ras-like GTPase controls αMβ2 function.
(a) TcdB-1470 (5 pg/ml) abolishes
PMA-induced CR3-mediated phagocytosis in
J774.A1 macrophages (mean ± SEM of three
independent experiments). (b) Activation of
αMβ2, or its inactivation by TcdB-1470, are
independent of changes in surface expression
of αM, as shown by flow cytometry. Top left,
isotype control; top right, resting cells; bottom
panels, PMA-stimulated cells preincubated
with medium (left) or TcdB-1470 (5 pg/ml;
right). Results are representative of three
independent experiments. FLH-1,
fluorescence intensity in arbitrary units.
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In vivo and in vitro, a variety of inflammatory signals can
activate β2-dependent functions in cells of the immune
system. In agreement with previous reports [21], we find
that three distinct agonists, TNF-α, LPS and PAF, induce
CR3-mediated phagocytic potential in J774 macrophages.
As with PMA, none of these affected surface expression of
αMβ2 (data not shown). To determine whether Rap1 also
mediates αMβ2 activation by inflammatory agents, domi-
nant-negative constructs were injected into macrophages
before addition of the inflammatory agents. Figure 3a,b
shows that dominant-negative Rap1, but not dominant-
negative R-ras, completely inhibited β2-dependent
phagocytosis induced by LPS, TNF-α and PAF. These
results argue for a specific role for Rap1 — not R-Ras— in
agonist-induced activation of β2 integrins in macrophages.
Why active R-ras promotes αMβ2 activation when overex-
pressed is not clear: it might activate Rap1 or a common
R-Ras/Rap1 effector.
Finally, to confirm that each of these agonists is capable of
activating endogenous Rap1, we have carried out pull-
down assays using a RalGDS–GST fusion protein, to
determine the levels of GTP-bound Rap1 in cells
(Figure 3c). Whereas control cells do contain detectable
levels of GTP-bound Rap1, all three inflammatory media-
tors induced a significant increase in Rap1 GTP levels
(Figure 3c, and data not shown), which preceded the
acquisition of phagocytic potential. 
Conclusions
In conclusion, we have identified three distinct receptors for
inflammatory mediators that induce functional activation of
the macrophage integrin, αMβ2, through a Rap1-controlled
signal transduction pathway. LPS and TNF-α interact with
the Toll/IL-1 and TNFR family of receptors, respectively,
which mediate their intracellular effects through adaptor-
like proteins such as Myd88, TRAFs and TRADD, whereas
PAF acts on a serpentine, G-protein-coupled receptor
[22–24]. As numerous Rap1-specific exchange factors
(GEFs) have been identified, it remains to be seen whether
one or more are involved downstream of these diverse fami-
lies of receptors [25,26]. The biochemical signals controlled
by Rap1 that mediate functional activation of the β2 integrin
are unclear, but they appear to be both necessary and suffi-
cient for integrin activation and do not function in these
cells by antagonizing Ras [19,27]. Because Ras does not acti-
vate αMβ2, the Rap1 effector that mediates this response
must be distinct from the known Ras effectors [28]. Similar
conclusions have recently been reported, and Rap1 activity
has been shown to control the stimulus-induced adhesion,
dependent on the cell adhesion molecule LFA-1, of stably
transfected cells to surfaces coated with the cell adhesion
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Figure 2
Rap1 function is sufficient for functional
activation of αMβ2 in macrophages and is
necessary for PMA-induced CR3-mediated
phagocytosis. (a) Expression of active R-Ras
(V-38) or Rap1 (V12) in J774.A1 cells
bypasses the need for cell activation for the
acquisition of CR3-dependent phagocytic
potential. Resting macrophages were
microinjected with biotin dextran (left panels),
Rap1 (V12) (centre panels) or R-Ras (V38)
(right panels), fed with red blood cells and
stained for biotin or Myc expression (top) and
red blood cell markers (bottom).
Phagocytosed particles appear swollen and
lie within vacuoles. The scale bar represents
10 µm. (b) Rap1 and R-Ras, but not Ras or
RalA, stimulate phagocytosis in macrophages.
(c) Rap1 but not R-Ras is necessary for PMA-
induced αMβ2 activation in macrophages.
(d) Rap1 controls the avidity of αMβ2 for its
ligand. C3bi-opsonized red blood cells
(C3bi–RBC) were incubated with non-
activated J774.A1 cells that had been
microinjected with various GTPase
constructs, or pretreated at 37°C with TcdB-
1470 (1 pg/ml, 2.5 h) or anti-CR3 M1/70
(25 µg/ml, 10 min, conditions that inhibit by
≥95% the number of C3bi-opsonized
particles that bind to CR3-transfected COS
cells, see [16]). Control (C) cells are injected
with lysine-fixable biotin dextran (10,000 MW,
Molecular Probes) and visualized with AMCA-
coupled streptavidin (Molecular Probes). In
(d), macrophages were incubated for 30 min
with opsonized particles, fixed and processed
for immunofluorescence as described, and the
total number of particles associated with the
cells was counted. Data are expressed as
mean ± SEM of at least three experiments, in
which a minimum of 35 positive cells were
counted per experiment.
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molecule ICAM-1, without affecting β2 surface expression
[29,30]. Furthermore, we show that Rap1 acts upstream of
the αMβ2 integrin to regulate its ability to bind C3bi-
opsonized particles. It is generally thought that three mech-
anisms can contribute to integrin activation: a change in
integrin affinity, by altering its conformation; an increase in
avidity through integrin clustering; or a change in the inter-
action of αMβ2 with the cytoskeleton [31]. There are con-
flicting reports about the mechanism(s) underlying
agonist-induced activation of αMβ2, and exposure of activa-
tion-specific epitopes and a role for the actin cytoskeleton
have both been proposed [32,33]. 
We previously showed that Rho acts downstream of CR3
to mediate phagocytosis in macrophages [16] and we show
here that Rap1 acts upstream of CR3 to regulate its activ-
ity. This nicely demonstrates the cooperation between
two distinct small GTPases to promote a coordinated bio-
logical response. Finally, it remains to be seen whether
Rap1 controls integrin activation in general; in this
respect, it is worth noting that Rap1 was first identified as
Krev-1, a gene able to induce flat revertants in Ras-trans-
formed cells [27]. Nevertheless, in view of its role in con-
trolling β2-integrin activation, both in macrophages, as
shown here, and in T cells [29,30], we would expect Rap1
to have a key role in inflammation and immunity in vivo. 
Materials and methods
R-Ras (V38), Rac (V12) and Rac (N17) [34,35] were subcloned into the
mammalian expression vector pRK5myc. Point mutations were intro-
duced by site-directed mutagenesis into wild-type constructs to generate
H-Ras (V12), H-Ras (N17), Rap1 (V12), Rap1 (N17), RalA (L72) and
R-Ras (N43), which were then subcloned into pRK5myc. pMT2-HA-
RapGAP and pMT2-HA-RalA (N28) were provided by Johannes Bos
(University of Utrecht, the Netherlands). Purified B toxins, isolated from
strains 1470 or 10463 of C. difficile (herein referred to as TcdB-1470
and TcdB–10463, respectively), were kind gifts of C. von Eichel-Streiber
(Johannes Gutenberg University, Mainz, Germany).
J774.A1 macrophage-like cells (American Type Culture Collection)
were grown in DMEM supplemented with 10% heat-inactivated FCS
(Sigma). They were treated with bacterial toxins for 2 h at 37°C in
serum-free medium (SFM) containing 10 mM HEPES. Cell activation
with PMA (Sigma), used at 150 pg/ml for 15 min, recombinant human
TNF-α (R&D Systems), used at 50 ng/ml for 30 min, or PAF (Cal-
biochem), used at 5 nM for 15 min was also performed in HEPES-sup-
plemented SFM. By constrast, LPS (from Escherichia coli 055:B5;
Sigma) was used at 100 ng/ml for 30 min in DMEM supplemented with
10% heat-inactivated FCS. In all cases, cells were quickly washed in
SFM before being used in subsequent assays.
For the analysis of αM surface expression, J774.A1 cells were treated
with various agonists or toxins as indicated above, then washed and
scraped in cold PBS supplemented with 0.5% BSA, 0.02% azide and
excess IgG, and subsequently stained using a rat monoclonal antibody
(M1/70, Pharmingen) and FITC-coupled anti-rat IgG (Jackson
ImmunoResearch Laboratories). Samples were run on a FACSCalibur
(Becton Dickinson) according to the manufacturer’s instructions and
data were analyzed using the CellQuest software. 
Microinjection of J774.A1 cells, the preparation of C3bi-opsonized red
blood cells, the phagocytic assay and the staining procedures have
been described before [16]. Briefly, cells were transferred to HEPES-
containing SFM immediately before injection. The tagged DNA con-
structs (0.1 mg/ml) were microinjected along with lysine-fixable
10,000 MW biotin dextran (Molecular Probes), at a final concentration
of 2.5 mg/ml, into the nucleus of at least 50 cells. Cells were returned
to the incubator for 2.5 h, to allow expression of the corresponding pro-
teins, before the phagocytic assay. In some experiments, cells were
activated with PMA or inflammatory molecules before the phagocytic
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Figure 3
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Rap1 is necessary for αMβ2 activation mediated by several
inflammatory mediators. (a,b) Dominant-negative Rap1 (N17) but not
R-Ras (N43) prevents activation of αMβ2 by TNF-α, PAF and LPS. In
(a) macrophages were injected with biotin dextran (top panels) or
Rap1 (N17) (bottom panels), activated with TNF-α and assayed for
phagocytosis. Left, injected cells; right, staining for red blood cells. The
scale bar represents 10 µm. (b) Macrophages were injected with biotin
dextran (C) or Myc-tagged constructs, then 2.5 h later were activated
with TNF-α (open bars), PAF (grey bars) or LPS (black bars) and used
in phagocytic assays. Results are given as mean ± SEM of at least
three experiments, except for TNF-α, where the mean of two
experiments is given. (c) PMA, LPS and PAF induce GTP loading on
Rap1. Top panel, pull-down of GTP-bound Rap1 from lysates of
control (C) or activated J774.A1 cells; bottom panel, total lysates
(corresponding to 2% of the amount of lysate used in pull-down
experiments) were run and probed with anti-Rap1 antibody by western
blotting. Results shown in each panel are representative of three
independent experiments.
challenge. C3bi-opsonized red blood cells, resuspended in HEPES-
buffered SFM, were fed to macrophages for 30 min (target-to-cell
ratio = 20) at 37°C. Cells were fixed in 4% paraformaldehyde for
20 min at 4°C and processed for immunofluorescence. Injected cells
were visualized using AMCA-coupled streptavidin (Molecular Probes).
Phagocytosis was, however, assessed only in the Myc- or haemagglu-
tinin (HA)-positive cells, visualized after immunofluorescent staining
using the 9E10 anti-Myc or the 3F10 anti-HA (Boehringer Mannheim)
monoclonal antibodies. Phagocytic index is defined as the number of
red blood cells internalized per 100 macrophages. 
Rap1 pull-downs were conducted essentially as described [36] using
20 µg GST–RalGDS–RBD and 2 × 107 J774.A1 cells per point. Cells
were kept in HEPES-supplemented SFM, or stimulated as indicated
with PMA (150 ng/ml), PAF (5 nM), serum-supplemented medium or
LPS (100 ng/ml) in serum-containing medium. Samples were run on
15% acrylamide SDS–PAGE gels, blotted and probed with a mono-
clonal anti-Rap1 antibody (Transduction Laboratories) followed by a
horseradish peroxidase-conjugated anti-mouse serum (Pierce) and
revealed by chemiluminescence (ECL kit, Amersham). 
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